Order results by:
| Issue | Title | |
| Vol 7, No 3 (2015) | Pharmacoeconomic analysis of the use of first- and second-line drugs in the treatment of multiple sclerosis | Abstract similar documents |
| V. R. Mkrtchyan, L. V. Brylev, O. V. Davydova, A. V. Belyanin, I. A. Shpak, A. M. Sergeev | ||
| "... Objective: to make a pharmacoeconomic comparison of the administration of first- and second-line ..." | ||
| Vol 16 (2024): (Suppl. 2) | Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaya, E. V. Lysogorskaia, A. N. Boyko | ||
| "... of first-line MS disease-modifying therapy (DMTs) is a very current issue. Such a boost is needed to reduce ..." | ||
| Vol 1, No 3-4 (2009) | RUSSIAN OBSERVATIONAL SURVEY OF THE SHORT-TERM EFFICACY AND TOLERABILITY OF SUSTAINED-RELEASE SODIUM VALPROATE (DEPAKINE CHRONOSPHERA®) AS A FIRST-LINE DRUG IN THE TREATMENT OF EPILEPSY | Abstract similar documents |
| E. D. Belousova, A. Yu. Ermakov | ||
| "... valproate (Depakine Chronosphera®, Sanofi- Aventis, France) used as both first-line monotherapy ..." | ||
| Vol 8, No 4 (2016) | USE OF DIMETHYL FUMARATE IN THE TREATMENT OF MULTIPLE SCLEROSIS: CLINICAL AND ECONOMIC ANALYSIS | Abstract similar documents |
| V. R. Mkrtchyan, L. V. Brylev, I. A. Shpak, A. M. Sergeev | ||
| "... evaluation was made to study the use of first-line oral dimethyl fumarate versus another first-line oral ..." | ||
| Vol 15 (2023): (Suppl. 1) | The evolution of interferon therapy in multiple sclerosis | Abstract similar documents |
| O. V. Boyko, N. F. Smirnova, A. N. Boyko | ||
| "... В статье приведен обзор эволюции интерферонов β (ИФНβ) в лечении рассеянного склероза (РС) от ..." | ||
| Vol 15, No 6 (2023) | Russian-Belarusian Expert Council “New opportunities in the treatment of patients with multiple sclerosis” (October 1, 2023). Main conclusions of the first meeting | Abstract similar documents |
| A. N. Boyko, V. V. Vashchilin, O. V. Boyko, A. G. Bunyak, D. S. Kasatkin, D. S. Korobko, S. I. Kulikova, N. V. Mazgo, N. V. Makovskaya, S. A. Sivertseva, I. V. Smagina, T. N. Chernukha | ||
| "... is an effective and safe drug of first choice (first-line treatment) for relapsing remitting MS. Divozilimab ..." | ||
| Vol 2, No 3 (2010) | Russian observational study of the efficacy and tolerability of depakine chrono as first-line monotherapy for focal epilepsy | Abstract similar documents |
| E. D. Belousova | ||
| "... as first-line monotherapy in patients with newly or recently diagnosed focal epilepsy. Subjects ..." | ||
| Vol 15 (2023): (Suppl. 1) | Prospects for the use of curcumin as an additional treatment for multiple sclerosis | Abstract similar documents |
| V. S. Rogovskii, A. D. Kukushkina, A. N. Boyko | ||
| "... effects (especially when second-line disease-modifying therapies (DMT) are used). In this context ..." | ||
| Vol 8, No 4 (2016) | GLATIRAMER ACETATE IS A FIRST-LINE DUAL-ACTION DRUG FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS | Abstract similar documents |
| T. E. Shmidt | ||
| Vol 7, No 3 (2015) | Review of the book: Fonyakin A.V., Geraskina L.A. Prevention of ischemic stroke. Guidelines for lipid-lowering therapy. Moscow: IMA-PRESS, 2015. – 72 p. | Abstract similar documents |
| Е. А. Широков | ||
| Vol 15, No 2 (2023) | Efficacy and safety of aceclofenac in musculoskeletal diseases | Abstract similar documents |
| M. A. Isaikina, A. I. Isaikin, L. T. Akhmedzhanova | ||
| "... arthritis and other diseases recommend oral non-steroidal anti-inflammatory drugs as first-line therapy ..." | ||
| Vol 15, No 2 (2023) | Diagnosis and therapy of obsessive-compulsive spectrum disorders in general medical and neurological practice | Abstract similar documents |
| D. S. Petelin, A. N. Gamirova, O. Yu. Sorokina, D. V. Troshina, S. A. Semin, M. Sh. Boltueva, B. A. Volel | ||
| "... inhibitors and cognitive behavioral therapy as first-line therapy is justified. ..." | ||
| Vol 15, No 2 (2023) | Optimization of migraine attacks relief | Abstract similar documents |
| G. R. Tabeeva, A. V. Amelin, L. R. Akhmadeeva, A. B. Danilov, O. B. Doronina, M. I. Koreshkina, N. V. Latysheva, E. G. Mendelevich, I. V. Sarvilina, A. V. Sergeev, K. V. Skorobogatykh, E. G. Filatova | ||
| "... and the effectiveness of triptans as first-line therapy, the choice of a specific drug in accordance with the individual ..." | ||
| Vol 12, No 5 (2020) | Chemotranscriptome analysis of the ethylmethylhydroxypyridine succinate molecule in the context of postgenomic pharmacology | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. I. Sorokin, V. A. Semenov, L. V. Stakhovskaya | ||
| "... .TAK cell line). Material and methods. The paper presents the results of chemotranscriptome analysis ..." | ||
| Vol 14, No 5 (2022) | Cervical radiculopathy | Abstract PDF (Eng) similar documents |
| A. I. Isaikin, T. E. Schmidt, Yu. M. Shor | ||
| "... is favorable. Rehabilitation programs are used as the first line of treatment, including a combination ..." | ||
| Vol 16, No 3 (2024) | Diffusion tensor tomography with tractography in assessment of the pyramidal system in patients with highly active multiple sclerosis | Abstract similar documents |
| A. N. Peshkin, G. T. Toniya, E. A. Stepanova, V. Yu. Lizhdvoi, S. V. Kotov | ||
| "... ) during treatment switching from first-line MS therapy to second-line therapy due to suboptimal response ..." | ||
| Vol 13, No 4 (2021) | Rehabilitation approaches in cervical dystonia | Abstract similar documents |
| Z. A. Zalyalova, E. R. Iusupova | ||
| "... disturbances, and pain. Current CD treatment guidelines include botulinum toxin (BT) injections as first-line ..." | ||
| Vol 9, No 2 (2017) | Role of a muscle factor in the development of low back pain | Abstract similar documents |
| A. I. Isaikin, G. E. Shevtsova, D. O. Rozhkov, A. V. Kavelina, M. A. Ivanova | ||
| "... , and nonsteroidal anti-inflammatory drugs as first-line analgesic agents. Meloxicam is noted to be highly effective ..." | ||
| Vol 10, No 3 (2018) | Alzheimer's disease: some pharmacological and non-pharmacological approaches to correcting neuropsychiatric disorders | Abstract similar documents |
| E. G. Mendelevich | ||
| "... have been increasingly used as priority-line therapy for NPDs. There are data on main methods for non ..." | ||
| Vol 5, No 2 (2013) | Current aspect of the diagnosis and management of migraine | Abstract similar documents |
| Marina Igorevna Koreshkina | ||
| "... in the diagnosis of migraine. The stratified approach where which first-line therapy is determined depending ..." | ||
| Vol 16 (2024): (Suppl. 2) | Experience with the use of cladribine tablets in real-life clinical practice: independent analysis of data from 12 Russian clinical centres | Abstract similar documents |
| A. N. Boyko, V. M. Alifirova, D. V. Pashkovskaya, E. I. Kuchina, S. A. Sivertseva, E. L. Turova, Z. A. Goncharova, O. Yu. Rudenko, Yu. Yu. Pogrebnova, F. A. Khabirov, T. I. Khaibullin, N. N. Babicheva, N. L. Khoroshilova, O. V. Dzundza, O. A. Soldatova, A. N. Belova, G. Е. Sheiko, A. Е. Makarova, N. G. Glavinskaya | ||
| "... .e. in these cases the drug was the first DMT prescribed. Among patients who had received a second-line DMTs before ..." | ||
| Vol 7, No 4 (2015) | Topical issues of the efficiency and safety of using the first direct thrombin inhibitor in real clinical practice | Abstract similar documents |
| A. V. Fonyakin | ||
| "... A Regional Expert Council meeting was held in Moscow on August 21, 2015 to consider different ..." | ||
| Vol 17, No 2 (2025) | Discogenic lumbar pain due to fibrous ring rupture | Abstract similar documents |
| A. I. Isaykin, L. T. Akhmedzhanova, N. V. Vakhnina, I. A. Isaykin | ||
| "... segments of a fibrous ring. The recommended first-line treatment for NLP is patient's education, tips ..." | ||
| Vol 16 (2024): (Suppl. 2) | Analysis of the experience with once-weekly intramuscular administration of interferon beta-1a in the Russian population of patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| F. A. Khabirov, E. V. Granatov, A. Ya. Dykhanov, T. I. Khaibullin | ||
| "... to other drugs of the interferon beta group were found. The spectrum and severity of AEs were in line ..." | ||
| Vol 13, No 5 (2021) | Evaluation and treatment of peripheral nervous system dysfunction in patients with prediabetes | Abstract similar documents |
| O. E. Zinovyeva, T. M. Ostroumova, M. V. Koniashova, N. A. Gorbachev | ||
| "... of neuropathic pain. In patients with painful DN, the first-line therapy includes pregabalin, gabapentin ..." | ||
| Vol 11, No 2 (2019) | Differential chemoreactome analysis of synergistic combinations of tolperisone and nonsteroidal anti-inflammatory drugs | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, V. A. Semenov, A. N. Gromov | ||
| "... and platelet aggregation; 4) vasodynamic effects; 5) antitumor properties on cell lines in culture. Results ..." | ||
| Vol 2, No 3 (2010) | Use of depakine chronosphere as a first monotherapy to treat epilepsy in children | Abstract similar documents |
| E. D. Belousova, A. Yu. Ermakov | ||
| "... -line monotherapy in the treatment of epilepsy in children without epileptic encephalopathy. Subjects ..." | ||
| Vol 6, No 2 (2014) | Postherpetic neuralgia: Therapeutic and prophylactic aspects and pregabalin therapy | Abstract similar documents |
| E.G. Mendelevich, S.V. Mendelevich | ||
| "... in the treatment of pain in PHN are demonstrated in numerous studies, is one of the most effective first-line drugs ..." | ||
| Vol 16, No 3 (2024) | Fremanezumab in real-life clinical practice: specialized headache center experience | Abstract similar documents |
| Yu. E. Azimova, K. V. Skorobogatikh, V. V. Osipova, D. Z. Korobkova, N. V. Vashchenko, E. Z. Mamkhegov, A. S. Galanina, E. A. Guziy | ||
| "... mAbs are considered the first-line treatment for migraine. ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Results of a study of the quality of life in patients with highly active multiple sclerosis in Russia | Abstract similar documents |
| A. N. Boiko, K. Z. Bakhtiyarova, M. A. Sherman, Z. A. Goncharova, I. V. Smagina, T. I. Khaibullin, N. N. Babicheva, N. N. Spirina, I. A. Yampolskaya-Gosteva, I. A. Sokolova, I. V. Greshnova, V. E. Nikitenkova, I. G. Lukashevich, A. V. Inzhinova, N. A. Malkova, D. S. Korobko, O. V. Boyko, I. S. Lozovskaya | ||
| "... second-line DMTsMS. ..." | ||
| No 1S (2016): | Russian experience with perampanel in routine clinical practice | Abstract similar documents |
| V. A. Karlov, O. V. Belyaev, P. N. Vlasov, I. A. Zhidkova, I. V. Volkov, D. V. Dmitrenko, A. Yu. Karas, T. V. Kazennykh, O. I. Miguskina, A. V. Moskvicheva, E. N. Paramonova, I. V. Ponomareva, A. V. Chervyakov | ||
| "... to the majority (71.2%) of patients after three previous therapy lines. The baseline monthly rates of all types ..." | ||
| Vol 16 (2024): (Suppl. 2) | High-dose immunosuppressive therapy followed by haematopoietic stem cell transplantation as a method for the treatment of refractory forms of neuromyelitis optica spectrum disorder in children | Abstract similar documents |
| N. N. Bronina, O. V. Bykova, G. O. Bronin, A. E. Kessel, G. Z. Seregin, K. I. Kirgizov, A. Yu. Polushin, T. T. Batysheva | ||
| "... of two lines of immunosuppressive therapy. PSCs were collected before auto-HSCT, but due to a further ..." | ||
| Online-first | The first experience with the use of ofatumumab for the treatment of pediatric multiple sclerosis in real-life clinical practice in Russia. A case series | Abstract similar documents |
| E. D. Kuzminykh, V. M. Lebedev, V. E. Senchenko, M. S. Cherepyansky, V. A. Gonchar, D. S. Korobko | ||
| "... with a four-year history of the disease showed resistance to first-line therapy (interferon β1a and glatiramer ..." | ||
| Vol 17, No 1 (2025) | The first experience with the use of ofatumumab for the treatment of pediatric multiple sclerosis in real-life clinical practice in Russia. A case series | Abstract similar documents |
| E. D. Kuzminykh, V. M. Lebedev, V. E. Senchenko, M. S. Cherepyansky, V. A. Gonchar, D. S. Korobko | ||
| "... with a four-year history of the disease showed resistance to first-line therapy (interferon β1a and glatiramer ..." | ||
| Vol 12, No 3 (2020) | A Russian retrospective multicenter open-label observational study based on medical documentation on the use of perampanel in everyday clinical practice | Abstract PDF (Eng) similar documents |
| P. N. Vlasov, V. A. Karlov, I. A. Zhidkova, D. V. Dmitrenko, I. G. Rudakova, T. V. Danilova, V. A. Kalinin, O. V. Grebenyuk, A. P. Gertsen, Ya. S. Zhuravlev, A. Yu. Karas, E. N. Paramonova, I. V. Ponomareva, O. I. Miguskina, N. A. Sobyanina, D. V. Sukhova, Yu. V. Salomatin, M. L. Ertakhova, T. M. Goguadze, A. P. Shamray | ||
| "... previous lines of therapy; before PEP administration, there was a maximum of 2 (50.9%) and 3 (29.6%) drugs ..." | ||
| Vol 13, No 3 (2021) | Depression treatment in women and men with bipolar affective disorder: a comparative study | Abstract similar documents |
| N. A. Tyuvina, A. E. Stolyarova, V. V. Balabanova, K. M. Bunkova, E. N. Efremova | ||
| "... duration was included in the analysis. In some patients with severe depression and infective first-line ..." | ||
| Vol 12, No 6 (2020) | Efficacy and safety of antipsychotics in adolescents with an acute psychotic episode in relation to the activity of CYP3A and CYP2D6 isoenzymes | Abstract similar documents |
| D. V. Ivashchenko, A. S. Osipov, E. V. Nazarova, M. A. Ovchinnikova, N. I. Buromskaya, V. V. Smirnov, P. V. Shimanov, R. V. Deitch, T. A. Fainshtein, E. N. Shagovenko, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Yu. S. Shevchenko, D. A. Sychev | ||
| "... Antipsychotics are a first-line treatment for psychotic disorders. The cytochrome P450 isoenzymes ..." | ||
| Vol 16, No 5 (2024) | The Effect of Adding Agomelatine to Escitalopram in the Treatment of Major Depressive Disorder | Abstract PDF (Eng) similar documents |
| H. Azadi, P. Rashidpour, S. M. Yassini Ardekani, M. Nadi Sakhvidi, H. Afshang, R. Bidaki | ||
| "... are the first line of treatment for major depression. Another drug that has been considered in the treatment ..." | ||
| Vol 2, No 1 (2010) | SUCCINIC ACID DERIVATIVES IN THERAPY FOR CEREBROVASCULAR DISEASE | Abstract similar documents |
| N. V. Pizova | ||
| "... in different forms of cerebrovascular disease. The use of oxidants is stated to be one of the lines of therapy ..." | ||
| Vol 7, No 2 (2015) | Interuniversity Scientific and Practical Conference on Psychosomatic Medicine in Russia: Advances and Prospects | Abstract similar documents |
| V. E. Medvedev | ||
| "... on Psychosomatic Medicine in Russia: Advances and prospects, held in Moscow on March 26, 2015, which ..." | ||
| Vol 12, No 1 (2020) | Gender characteristics of therapy for genetic generalized epilepsy in adults | Abstract similar documents |
| I. V. Volkov, G. S. Karpovich, A. V. Kalina, O. K. Volkova | ||
| "... was changed after the appearance of the 2015 International League against Epilepsy (ILAE) recommendations ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | Long-term levetiracetam monotherapy for partial epilepsy in adults | Abstract similar documents |
| P. N. Vlasov, V. A. Karlov, E. G. Komelkova, Z. S. Shakhabasova | ||
| "... patients aged 16—73 years with partial epilepsy. LTC was used as first-line monotherapy in 71 patients ..." | ||
| Vol 13, No 2 (2021) | Malnutrition and perspectives of nutritional therapy for mental disorders | Abstract similar documents |
| D. V. Romanov, K. Yu. Dmitrenko | ||
| "... . The potential of using the products of the Fresubin line is analyzed in detail. ..." | ||
| Vol 1, No 1 (2009) | CARE TO PATIENTS WITH PRIOR STROKE | Abstract similar documents |
| A. G. Gutsalyuk, A. N. Komarov, A. G. Merkin | ||
| "... for the relatives of stroke patients. The major aspects and lines of SRSP activities are described in this paper. ..." | ||
| Vol 5, No 1 (2013) | Mild and moderate cognitive impairments: clinical manifestations, etiology, pathogenesis, treatment approaches | Abstract similar documents |
| Irina Sergeyevna Preobrazhenskaya | ||
| "... in MCI are detailed in relation to their etiology. The main lines of MCI treatment and the data ..." | ||
| Vol 15, No 5 (2023) | Problems in the selection of effective analgesics for migraine | Abstract similar documents |
| G. R. Tabeeva | ||
| "... купирования головной боли. В ряду рекомендованных лекарственных средств триптаны являются первой линией ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Gastric stasis in migraine and the efficacy of antimigraine drugs | Abstract similar documents |
| G. R. Tabeeva, A. A. Kharitonova | ||
| "... this form favorable as a first-line agent for the relief of migraine attacks. ..." | ||
| Vol 8, No 3 (2016) | Prevention of cerebrovascular diseases and cognitive impairment in psychiatric and neurological practice: A literature review | Abstract similar documents |
| A. G. Merkin, V. A. Kazhin, A. N. Komarov, A. V. Fonarev, V. A. Priyatel, I. A. Nikiforov | ||
| "... и физическая активность могут рассматриваться как первая линия защиты от развития и прогрессирования ..." | ||
| Vol 8, No 1 (2016) | Factors determining social (interpersonal) support in patients with vertebro-spinal cord injury | Abstract similar documents |
| I. D. Boulyubash, O. S. Bashta | ||
| "... skills assessment by the patients. Patients and methods. In 2014–2015, a psychodiagnostic study ..." | ||
| No 1S (2016): | The epidemiology of afebrile seizures in the pediatric population of the Trans-Baikal Territory | Abstract similar documents |
| N. A. Marueva, N. A. Shnaider, A. V. Shulmin, Yu. A. Shirshov, G. A. Goltvanitsa, E. V. Leontyeva | ||
| "... ) from the Trans-Baikal Territorial Antiepileptic Center (TAEC) over 2004–2015 were retrospectively ..." | ||
| Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ | The characteristics of social adaptation in reproductive-aged women with epilepsy and migraine | Abstract similar documents |
| G. V. Odintsova, M. V. Aleksandrov, S. V. Nesterova | ||
| "... health of epilepsy women, which has been conducted since 2015 according to Russian Foundation for Basic ..." | ||
| Vol 9, No 2 (2017) | Mental status in pregnant women with brain injury sequels | Abstract similar documents |
| A. A. Volynkin, P. N. Vlasov, V. A. Petrukhin, K. N. Akhvlediani | ||
| "... -2015, were examined. All the patients underwent a comprehensive neurological and neuropsychological ..." | ||
| Vol 15 (2023): (Suppl. 1) | Delayed diagnosis of the neuromyelitis optica spectrum disorder | Abstract similar documents |
| S. A. Dzhukkaeva, E. V. Ermilova, Sh. R. Nabiev, O. N. Voskresenskaya | ||
| "... demyelinating diseases of the central nervous system. In 2015, International Expert Panel established diagnostic ..." | ||
| Vol 9, No 1 (2017) | Correction of sleep disorders in EMERCOM employees: The results of using long-acting melatonin | Abstract similar documents |
| Yu. B. Slizkova, V. A. Bryuzgin | ||
| "... be recommended as a first-line drug to treat desynchronosis-associated sleep disorders. ..." | ||
| Vol 12, No 5 (2020) | Endovascular treatment results in patients with large cerebral artery occlusions in a metropolis. Moscow Stroke Registry data over 2019 | Abstract PDF (Eng) similar documents |
| D. V. Skrypnik, K. V. Anisimov, A. Yu. Botsina, T. V. Kiseleva, S. P. Grachev, N. A. Shamalov, E. Yu. Vasilyeva, A. V. Shpektor | ||
| "... in the 2015 American Heart Association/American Stroke Association (AHA/ASA) guidelines, which included a pre ..." | ||
| Vol 8, No 2 (2016) | Glatiramer acetate 40 mg/ml: A review of the results of GALA and GLACIER clinical studies | Abstract similar documents |
| N. Yu. Lashch, A. N. Boiko | ||
| "... for the treatment of patients with RRMS. In the Russian Federation, GA 40 mg was approved for use in September 2015. ..." | ||
| Vol 9, No 4 (2017) | In-hospital stroke in patients after cardiac surgery or invasive interventions | Abstract similar documents |
| P. A. Filimonova, L. I. Volkova, A. M. Alasheev, A. V. Mikhaylov, E. A. Grichuk | ||
| "... in Sverdlovsk Regional Hospital One in 2011 to 2015. A comparison group consisted of 196 patients with community ..." | ||
| No 1S (2016): | Partial epilepsies: Choice of antiepileptic drugs in adults in the outpatient setting | Abstract similar documents |
| P. N. Vlasov | ||
| "... to be now a first-line choice drug for the therapy of undifferentiated, cryptogenic, and symptomatic partial ..." | ||
| Vol 4, No 1 (2012) | Generalized epilepsies: current conceptions and therapeutic approaches | Abstract similar documents |
| L R Zenkov | ||
| "... chromosphere) have a priority as first-line drugs for the initial treatment of generalized epilepsies ..." | ||
| Vol 12, No 4 (2020) | Chemotranscriptome analysis indicates the neurotrophic and neuromodulator effects of a citicoline molecule | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, V. A. Semenov, I. A. Shchukin | ||
| "... . Хемотранскриптомный анализ молекулы ЦТК проводился на модели нейронов линии NPC.TAK при условии инкубации клеток с ЦТК ..." | ||
| Vol 5, No 1S (2013): Special issue "Epilepsy" | Efficiency and tolerance of sustained-release valproate sodium (Depakine®ChronosphereТМ) as the drug of the first choice in the treatment of adult epilepsy | Abstract similar documents |
| E. D. Belousova, G. N. Avakyan | ||
| "... -line agent for monotherapy in the treatment of adult epilepsy. Patients and methods. The short-term ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Evaluation of the efficacy of preventive therapy in chronic migraine with or without medication overuse headache: data from a prospective study | Abstract similar documents |
| E. A. Guziy, A. V. Sergeev, G. R. Tabeeva | ||
| "... with venlafaxine or topiramate. Conclusion. All first-line drugs for the CM prophylactic treatment according ..." | ||
| Vol 13, No 5 (2021) | Awareness of cardiovascular diseases risk factors, attitude towards their health and sleep disorders among the 25–64 years old population in Russia/Siberia (WHO International «MONICA-psychosocial» program) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. N. Tripelhorn, A. V. Gafarova | ||
| "... age– 35±0.4 years, response rate – 72%); in 2015–2018 – VI screening (275 men, mean age – 49±0.4 years ..." | ||
| Vol 15, No 4 (2023) | Psychosocial factors and sleep disorders in the population aged 25–64 years in Russia/Siberia (International WHO MONICA-Psychosocial Programme) | Abstract similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. V. Gafarova | ||
| "... .4 years, response rate 71%; 548 women, mean age 35±0.4 years, response rate 72%); in 2015–2018 (VI ..." | ||
| Vol 5, No 1 (2013) | Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease | Abstract similar documents |
| Oleg Semenovich Levin, V K Datiyeva | ||
| "... amantadine, 4 had a fixed-dose of rasagi- line. The dose titration of Requip Modutab was 4 to 8 weeks ..." | ||
| Vol 16, No 3 (2024) | Clinical and neurophysiological features of the augmentation phenomenon in restless legs syndrome | Abstract similar documents |
| N. A. Gorbachev, A. V. Obukhova, L. A. Fedeneva, M. G. Poluektov | ||
| "... случаев заболевание сопровождается когнитивными нарушениями и ухудшением качества жизни. Основной линией ..." | ||
| 1 - 67 of 67 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
